Insider · CIK 0001925150
Marc Duey
Files at APRE (Aprea Therapeutics, Inc.). First filing Oct 16, 2024, latest Oct 25, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
APRE: Aprea Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | APREsell Aprea Therapeutics, Inc. | $30k 6,462 shares | -3% | - | |
| 49Moderate | Aprea Therapeutics, Inc. | $132k 30,000 shares | +14% | - | |
| 25Weak | Aprea Therapeutics, Inc. | $490 190 shares | +0% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 18, 2024 | APRE Aprea Therapeutics, Inc. | SOpen-market sale Common Stock | -6,462 | $4.58 | $30k | 233,651 | Oct 25, 2024 |
| Oct 16, 2024 | APRE Aprea Therapeutics, Inc. | POpen-market purchase Common Stock | +30,000 | $4.39 | $132k | 240,113 | Oct 17, 2024 |
| Oct 14, 2024 | APRE Aprea Therapeutics, Inc. | POpen-market purchase Common Stock | +190 | $2.58 | $490 | 210,113 | Oct 16, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.